🔎 Trials Near Me

Akèy › Degeneresans makile

Etid klinik pou Degeneresans makile ap rekrite nan Etazini

55 etid pou Degeneresans makile ap rekrite patisipan nan sit atravè Etazini.

Vil ki gen plis etid

Pa eta

Etid ki fèk mete ajou

Tèks ofisyèl etid la (Anglè)

National Eye Institute Biorepository for Retinal Diseases

Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 2 a 120 · Tout sèks · Mizajou Sep 28, 2026 · NCT01496625

Cell Collection to Study Eye Diseases

Ap rekriteEtid obsèvasyonVolontè an sante akeyi
1 Day – 120 Years · Tout sèks · Mizajou Sep 22, 2026 · NCT01432847

A Study in Adults With Geographic Atrophy

Ap rekriteFaz 2
Laj 60 ak plis · Tout sèks · Mizajou Sep 21, 2026 · NCT07606365

A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-002)

Ap rekriteFaz 2/3
Laj 50 ak plis · Tout sèks · Mizajou Sep 18, 2026 · NCT07440225

A Phase 2 Study of NT-101 Topical in Patients With Wet AMD

Ap rekriteFaz 2
Laj 50 ak plis · Tout sèks · Mizajou Sep 16, 2026 · NCT07811726

The Effects of Disulfiram (Antabuse®) on Visual Acuity in Patients With Retinal Degeneration

Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Sep 16, 2026 · NCT06319872

Study to Evaluate Efficacy and Safety of ONL1204 in Patients With GA Associated With AMD

Ap rekriteFaz 2
Laj 55 ak plis · Tout sèks · Mizajou Sep 10, 2026 · NCT06659445

A Non-Interventional Study Observing Short-Term Progression in Geographic Atrophy (GA)

Ap rekriteEtid obsèvasyon
Laj 55 ak plis · Tout sèks · Mizajou Sep 3, 2026 · NCT07144137

Noninvasive Imaging Biomarkers of Treatable Macrovascular Disease in Age-related Macular Degeneration.

Ap rekriteEtid obsèvasyon
Laj 50 a 80 · Tout sèks · Mizajou Sep 3, 2026 · NCT07798323

A Long-term Follow-up Study to Evaluate SKG0106 in the Treatment of Patients With nAMD

Ap rekriteEtid obsèvasyon
Laj 50 ak plis · Tout sèks · Mizajou Sep 1, 2026 · NCT06346600

Effect of Lutein, Zeaxanthin, and Meso-Zeaxanthin Supplementation on Skin Carotenoid Concentration: A Six-Month, Placebo-Controlled Crossover Study

Ap rekriteVolontè an sante akeyi
Laj 18 ak plis · Tout sèks · Mizajou Sep 1, 2026 · NCT06965426

Microcurrent Stimulation Therapy for Intermediate to Advanced Nonexudative Age-related Macular Degeneration

Ap rekrite
Laj 60 ak plis · Tout sèks · Mizajou Aug 26, 2026 · NCT06662162

SGLT2 Inhibitors in Geographic Atrophy

Ap rekriteFaz 2
Laj 50 ak plis · Tout sèks · Mizajou Aug 26, 2026 · NCT07174687

A Study to Learn How Stargardt-type Eye Conditions Progress in Children and Adults

Ap rekriteEtid obsèvasyon
Laj 6 ak plis · Tout sèks · Mizajou Aug 25, 2026 · NCT07425574

4D-150 in Patients With Neovascular (Wet) Age-Related Macular Degeneration

Ap rekriteFaz 1/2
Laj 50 ak plis · Tout sèks · Mizajou Aug 21, 2026 · NCT05197270

Phase 1 Study of C.001 in Retinal Degeneration

Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Aug 17, 2026 · NCT07594236

AMD and Validation Rod-Meditated Dark Adaptation With Everyday Task Performance

Ap rekriteVolontè an sante akeyi
Laj 50 a 89 · Tout sèks · Mizajou Aug 10, 2026 · NCT06619405

A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-003)

Ap rekriteFaz 2/3
Laj 50 ak plis · Tout sèks · Mizajou Aug 6, 2026 · NCT07496567

Intravitreal (IVT) Pozelimab for Geographic Atrophy (GA) in Adult Participants

Ap rekriteFaz 1
Laj 50 ak plis · Tout sèks · Mizajou Aug 5, 2026 · NCT07230834

Sous ClinicalTrials.gov, done yo ranmase Oct 1, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.